Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danhong injection dose–effect in acute myocardial infarction
ChiCTR2500111341Phase 4Completed
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Oct 2025
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of danhong injection in myocardial infarction (MI) (2 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoints: Change rate of left ventricular systolic function (LVEF) and Traditional Chinese medicine syndrome score. Started Oct 2025; status: completed.
02
Drugs
danhong injection
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR2500111341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111341.